Sign in
TerminatedNo phase

Nanowear Heart Failure Management Multi-sensor Algorithm

Key facts

Who runs it
Nanowear Inc.
Where
Hershey, United StatesSee the site
Trial code
Status
Terminated
People taking part
13 people enrolled
Started
21 Aug 2019
Ended
18 Jun 2024
Type of study
Observational
Treatments tested
  • SimpleSENSE
Record updated
9 April 2026
Why it stopped
Logistics and low enrollment.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Subject has provided informed consent
  • Male or female over the age of 18 years
  • The patient is either hospitalized with a primary diagnosis of acute or was discharged with a primary diagnosis of acute heart failure within 2 weeks prior to enrollment
  • NYHA functional class II-IV at time of enrollment

Who cannot take part

  • Subjects who are hemodynamically unstable requiring support with intravenous vasoactive medications or mechanical circulatory support
  • Subject unwilling or unable to comply with wearing the Nanowear Congestive Heart Failure Management System 12 hours daily for up to 90 days
  • Subjects who are limited by angina
  • Symptomatic ventricular arrhythmias within the past 6 months
  • Severe aortic stenosis
  • Subjects who are pregnant will be excluded from this study

Where in United States

  • Penn State Health Milton S. Hershey Medical CenterHershey, United States

About the trial

What the trial wants to find out

The NanoSense study is a multi-center, prospective, non-randomized, observational, feasibility, non-significant risk study. The NanoSense study will enroll up to 500 subjects in up to 10 centers in order to collect data which includes at least 150 heart failure hospitalizations in participating subjects.The duration of the NanoSense study is expected to be 2 years. The study device is the Wearable Congestive Heart Failure Management System (WCHFS, also known as SimpleSENSE)

The group in the trial

  • Heart Failure Patients

    Patients with primary diagnosis as heart failure

    Treatment: SimpleSENSE

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Nanowear Wearable Heart Failure Management System Multiple Sensor Algorithm Development and Validation Trial
Record updated
9 April 2026